化学
组合化学
对接(动物)
配体(生物化学)
药物发现
细胞毒性
酶
配体效率
模板
立体化学
计算生物学
生物化学
纳米技术
受体
生物
体外
医学
护理部
材料科学
作者
Yao Wu,Changming Liu,Lei Hu
标识
DOI:10.1021/acsmedchemlett.2c00405
摘要
Efforts to combine advantages of fragment-based drug design (FBDD) and dynamic combinatorial chemistry (DCC) for the development of selective α-glucosidase inhibitors were described. Starting from 5 rationally designed fragments, two iterative dynamic combinatorial libraries (DCLs) comprising 29 acylhydrazone products were generated and screened using α-glucosidase and α-amylase as the templates. The optimal ligand identified showed substantial α-glucosidase inhibition with high selectivity over α-amylase as well as low cytotoxicity. Furthermore, inhibition type and detailed ligand/enzyme binding interactions were elucidated by the binding kinetic study and docking simulation, respectively.
科研通智能强力驱动
Strongly Powered by AbleSci AI